Search for content, post, videos

AstraZeneca’s new COVID-19 drug to be manufactured in Sweden

The last manufacturing steps of the company's Evusheld (previously AZD7442) will take place in Södertälje, Sweden. Packaging and release of the potential new drug, a combination of long-acting antibodies that both prevent and treat COVID-19, has already begun in Södertälje – AstraZeneca's l
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.